With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...

A study investigating whether a lesser known and under-reported side-effect of some chemotherapy medicines has a greater ...

Dr Zain Hasan, a Los Angeles-based anesthetist, warned his 636,000 followers on TikTok over the common drugs that could be ...

Discover how cancer cells survive in low-glucose environments and evade chemotherapy-induced death. New study sheds light on ...

Gold is shining in a surprising new way—not as jewelry, but as a potential cancer treatment. Researchers from RMIT University ...

The Princess of Wales has urged the public to change its attitude towards those dependent on drink or drugs - saying ...

Targeting Transformative Solutions for Aplastic Anemia and Beyond SAN DIEGO, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC Pink: RGBP and RGBPP) today provided further insight into its ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal carcinoma, in India.

Dr. Reddys has launched Toripalimab, a novel immuno-oncology drug, in India for treating recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). Toripalimab, already approved by USFDA and EMA, will ...

Dr Reddy's Laboratories has launched Toripalimab, a groundbreaking drug for treating recurrent or metastatic nasopharyngeal carcinoma (NPC) in India. The drug, marketed as Zytorvi, addresses an unmet ...

A new gold-based drug slows tumor growth by 82% in animals and targets cancer cells more precisely than chemotherapy.

The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...